Connected Biosensors - Asia

Asia

Highlights

The market Connected Biosensors in Asia is expected to achieve a revenue of US$7.16bn by 2024.
It is projected to exhibit a compound annual growth rate (CAGR 2024-2029) of 6.69%, leading to a market volume of US$9.90bn by 2029.
The user penetration rate is anticipated to be 1.94% in 2024 and is forecasted to increase to 2.00% by 2029.
The average revenue per user (ARPU) is expected to be US$81.38.
In terms of global comparison, China is set to generate the highest revenue, amounting to US$4.49bn in 2024.
In Asia, Japan is leading the way in the adoption of connected biometric sensors in the digital health market.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Connected Biosensors market in Asia is experiencing significant growth and development, driven by various factors shaping consumer preferences and market trends in the region.

Customer preferences: Consumers in Asia are increasingly prioritizing health and wellness, leading to a growing demand for connected biosensors such as smart thermometers, smart blood glucose meters, smart blood pressure meters, and social alarms. With a rising awareness of preventive healthcare and the convenience offered by these devices, customers are inclined towards adopting connected biosensors to monitor their health parameters regularly.

Trends in the market: In countries like Japan, known for its aging population, there is a strong emphasis on remote patient monitoring and telehealth solutions. This trend has fueled the adoption of smart biosensors, particularly among the elderly population and individuals with chronic conditions. The integration of these devices with telemedicine platforms and mobile apps is further driving market growth in the country.

Local special circumstances: China, being one of the largest markets for connected biosensors in Asia, is witnessing a surge in the adoption of these devices due to the government's initiatives to promote digital health and wearable technology. The increasing penetration of smartphones and internet connectivity in rural areas is also contributing to the widespread acceptance of smart biosensors among the Chinese population.

Underlying macroeconomic factors: The economic development and increasing disposable income levels in countries like South Korea and Singapore are influencing the growth of the connected biosensors market. As consumers become more health-conscious and tech-savvy, they are willing to invest in advanced healthcare devices for personalized monitoring and management of their health conditions. Additionally, government support for digital health initiatives and the presence of key market players in the region are driving innovation and market expansion in Asia.

Data coverage:

The data encompasses B2C enterprises. Figures are based on revenues and user data of relevant mobile applications and consumer electronics companies.

Modeling approach / Market size:

Market sizes are determined through a combined top-down and bottom-up approach, building on a specific rationale for each market segment. As a basis for evaluating markets, we use annual financial reports of key players, industry reports, third-party reports, and survey results from primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as GDP, population, internet penetration, smartphone penetration, consumer spending, and healthcare spending. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, the S-curve function and exponential trend smoothing are well suited for forecasting digital products and services due to the non-linear growth of technology adoption.

Additional notes:

The market is updated twice a year in case market dynamics change. The impact of the COVID-19 pandemic and the Russia-Ukraine war is considered at a country-specific level.